These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24312683)

  • 1. Advances in the Treatment of Pancreatic Neuroendocrine Tumors (pNETs).
    Strosberg J
    Gastrointest Cancer Res; 2013 Jul; 6(4 Suppl 1):S10-2. PubMed ID: 24312683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis.
    Mujica-Mota R; Varley-Campbell J; Tikhonova I; Cooper C; Griffin E; Haasova M; Peters J; Lucherini S; Talens-Bou J; Long L; Sherriff D; Napier M; Ramage J; Hoyle M
    Health Technol Assess; 2018 Sep; 22(49):1-326. PubMed ID: 30209002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on gastroenteropancreatic neuroendocrine tumors.
    Cives M; Strosberg J
    Oncology (Williston Park); 2014 Sep; 28(9):749-56, 758. PubMed ID: 25224471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroenteropancreatic Neuroendocrine Tumors.
    Cives M; Strosberg JR
    CA Cancer J Clin; 2018 Nov; 68(6):471-487. PubMed ID: 30295930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of everolimus in adult patients with neuroendocrine tumors.
    Oberstein PE; Saif MW
    Clin Med Insights Oncol; 2012; 6():41-51. PubMed ID: 22253554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic neuroendocrine tumors: entering a new era.
    Oberstein PE; Remotti H; Saif MW; Libutti SK
    JOP; 2012 Mar; 13(2):169-73. PubMed ID: 22406593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic neuroendocrine tumors: approach to treatment with focus on sunitinib.
    Vinik AI; Raymond E
    Therap Adv Gastroenterol; 2013 Sep; 6(5):396-411. PubMed ID: 24003340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy with capecitabine and temozolomide for unresectable pancreatic neuroendocrine tumor.
    Devata S; Kim EJ
    Case Rep Oncol; 2012 Sep; 5(3):622-6. PubMed ID: 23275776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETS): current approaches and future options.
    Strosberg JR
    Endocr Pract; 2014 Feb; 20(2):167-75. PubMed ID: 24014009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors.
    Cives M; Pelle' E; Quaresmini D; Mandriani B; Tucci M; Silvestris F
    Curr Treat Options Oncol; 2019 Jul; 20(9):72. PubMed ID: 31346813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of capecitabine/temozolomide (CAPTEM) regimen in the treatment of metastatic pancreatic neuroendocrine tumors (pNETs) after failing previous therapy.
    Saif MW; Kaley K; Brennan M; Garcon MC; Rodriguez G; Rodriguez T
    JOP; 2013 Sep; 14(5):498-501. PubMed ID: 24018594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor.
    Yoo C; Cho H; Song MJ; Hong SM; Kim KP; Chang HM; Chae H; Kim TW; Hong YS; Ryu MH; Kang YK; Kim SC; Ryoo BY
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):139-146. PubMed ID: 27942928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.
    Krug S; Gress TM; Michl P; Rinke A
    Digestion; 2017; 96(2):67-75. PubMed ID: 28728148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors.
    Miljković MD; Girotra M; Abraham RR; Erlich RB
    Dig Dis Sci; 2012 Jan; 57(1):9-18. PubMed ID: 21938486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms.
    Al-Toubah T; Morse B; Strosberg J
    Oncologist; 2020 Jan; 25(1):e48-e52. PubMed ID: 31455747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Overview on the Sequential Treatment of Pancreatic Neuroendocrine Tumors (pNETs).
    Alonso-Gordoa T; Díez JJ; Molina J; Reguera P; Martínez-Sáez O; Grande E
    Rare Cancers Ther; 2015; 3(1):13-33. PubMed ID: 27182476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trial.
    Neychev V; Steinberg SM; Cottle-Delisle C; Merkel R; Nilubol N; Yao J; Meltzer P; Pacak K; Marx S; Kebebew E
    BMJ Open; 2015 May; 5(5):e008248. PubMed ID: 25991462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will clinical heterogeneity of neuroendocrine tumors impact their management in the future? Lessons from recent trials.
    Cives M; Soares HP; Strosberg J
    Curr Opin Oncol; 2016 Jul; 28(4):359-66. PubMed ID: 27138571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic neuroendocrine tumors: a review.
    Young K; Iyer R; Morganstein D; Chau I; Cunningham D; Starling N
    Future Oncol; 2015; 11(5):853-64. PubMed ID: 25757686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic therapy for advanced pancreatic neuroendocrine tumors.
    Kulke MH
    Semin Oncol; 2013 Feb; 40(1):75-83. PubMed ID: 23391115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.